Preparation and evaluation of hepatic stellate cell selective, surface conjugated, peroxisome proliferator-activated receptor-gamma ligand loaded liposomes

Journal of Drug Targeting

Volumn 20, Issue 2, 2012, Pages 155-165

  Patel, Gaurang ^a   Kher, Gitanjali ^a   Misra, Ambikanandan ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Carbon tetrachloride; Conjugated liposomes; Hepatic stellate cell; Liver fibrosis; Liver targeting; Mannose 6 phosphate; Peroxisome proliferator activated receptor

Indexed keywords

CARBON TETRACHLORIDE; HUMAN SERUM ALBUMIN; LIPOSOME; MANNOSE 6 PHOSPHATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG MECHANISM; DRUG TISSUE LEVEL; DRUG UPTAKE; HISTOPATHOLOGY; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STELLATE CELL;

ALBUMINS; ANIMALS; BIOLOGICAL AVAILABILITY; BIOLOGICAL MARKERS; CARBON TETRACHLORIDE; DRUG DELIVERY SYSTEMS; HEPATIC STELLATE CELLS; HUMANS; INJECTIONS, INTRAVENOUS; LIPOSOMES; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MANNOSEPHOSPHATES; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLIDINEDIONES;

EID: 84855670506     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2011.610800     Document Type: Article

References (55)

1. Adrian JE, Kamps JA, Scherphof GL, Meijer DK, van Loenen-Weemaes AM, Reker-Smit C, Terpstra P, Poelstra K. (2007). A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats. Biochim Biophys Acta, 1768, 1430-1439. (Pubitemid 46795479)
2. Adrian JE, Poelstra K, Scherphof GL, Molema G, Meijer DK, Reker-Smit C, Morselt HW, Kamps JA. (2006). Interaction of targeted liposomes with primary cultured hepatic stellate cells: Involvement of multiple receptor systems. J Hepatol, 44, 560-567. (Pubitemid 43227881)
3. Bataller R, Brenner DA. (2001). Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis, 21, 437-451. (Pubitemid 32923771)
4. Bataller R, Brenner DA. (2005). Liver fibrosis. J Clin Invest, 115, 209-218. (Pubitemid 40385459)
5. Beljaars L, Molema G, Weert B, Bonnema H, Olinga P, Groothuis GM, Meijer DK, Poelstra K. (1999). Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells. Hepatology, 29, 1486-1493. (Pubitemid 29211051)
6. Beljaars L, Olinga P, Molema G, de Bleser P, Geerts A, Groothuis GM, Meijer DK, Poelstra K. (2001). Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P (2)-HSA). Liver, 21, 320-328. (Pubitemid 32910556)
7. Blomhoff R, Wake K. (1991). Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. FASEB J, 5, 271-277. (Pubitemid 21892886)
8. Blouin A, Bolender RP, Weibel ER. (1977). Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study. J Cell Biol, 72, 441-455. (Pubitemid 8030011)
9. Bottcher CSF, van Gent CM, Fries C. (1961). A rapid and sensitive submicro phosphorus determination. Anal Chim Acta, 24, 203-204.
10. Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W. (1996). Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology, 137, 354-366. (Pubitemid 26005011)
11. Cao Q, Mak KM, Lieber CS. (2002). Dilinoleoylphosphatidylcholine prevents transforming growth factor-beta1-mediated collagen accumulation in cultured rat hepatic stellate cells. J Lab Clin Med, 139, 202-210. (Pubitemid 34557355)
12. Constandinou C, Henderson N, Iredale JP. (2005). Modeling liver fibrosis in rodents. Methods Mol Med, 117, 237-250.
13. Dasí F, Benet M, Crespo J, Crespo A, Aliño SF. (2001). Asialofetuin liposome-mediated human alpha1-antitrypsin gene transfer in vivo results in stationary long-term gene expression. J Mol Med, 79, 205-212. (Pubitemid 32441899)
14. De Bleser PJ, Scott CD, Niki T, Xu G, Wisse E, Geerts A. (1996). Insulinlike growth factor II/mannose 6-phosphate-receptor expression in liver and serum during acute CCl4 intoxication in the rat. Hepatology, 23, 1530-1537. (Pubitemid 26181237)
15. de Bleser PJ, Jannes P, van Buul-Offers SC, Hoogerbrugge CM, van Schravendijk CF, Niki T, Rogiers V, van den Brande JL, Wisse E, Geerts A. (1995). Insulinlike growth factor-II/mannose 6-phosphate receptor is expressed on CCl4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factorbeta in cocultures with sinusoidal endothelial cells. Hepatology, 21, 1429-1437.
16. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. (1956). Colorimetric method for determination of sugars and related substances. Anal Chem, 28, 350-356.
17. Eng FJ, Friedman SL. (2000). Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex. Am J Physiol Gastrointest Liver Physiol, 279, G7-G11. (Pubitemid 30612679)
18. Enzan H, Himeno H, Iwamura S, Saibara T, Onishi S, Yamamoto Y, Hara H. (1994). Immunohistochemical identification of Ito cells and their myofibroblastic transformation in adult human liver. Virchows Arch, 424, 249-256. (Pubitemid 24157882)
19. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. (1995). 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell, 83, 803-812. (Pubitemid 3006324)
20. Friedman SL. (1990). Cellular sources of collagen and regulation of collagen production in liver. Semin Liver Dis, 10, 20-29. (Pubitemid 20163703)
21. Friedman SL. (1996). Hepatic stellate cells. Prog Liver Dis, 14, 101-130. (Pubitemid 26381337)
22. Friedman SL. (2003). Liver fibrosis? from bench to bedside. J Hepatol, 38 Suppl 1, S38-S53.
23. Friedman SL, Roll FJ, Boyles J, Arenson DM, Bissell DM. (1989). Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem, 264, 10756-10762. (Pubitemid 19161648)
24. Friedman SL, Yamasaki G, Wong L. (1994). Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo. J Biol Chem, 269, 10551-10558.
25. Galli A, Crabb D, Price D, Ceni E, Salzano R, Surrenti C, Casini A. (2000). Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology, 31, 101-108. (Pubitemid 30033695)
26. Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Svegliati-Baroni G, Ridolfi F, Trozzi L, Surrenti C, Casini A. (2002). Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology, 122, 1924-1940. (Pubitemid 34651436)
27. Geerts A. (2001). History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis, 21, 311-335. (Pubitemid 32923763)
28. Ginès P, Càrdenas A, Arroyo V, Rodés J. (2004). Management of cirrhosis and ascites. N Engl J Med, 350, 1646-1654.
29. Gonzalo T, Talman EG, van de Ven A, Temming K, Greupink R, Beljaars L, Reker-Smit C, Meijer DK, Molema G, Poelstra K, Kok RJ. (2006). Selective targeting of pentoxifylline to hepatic stellate cells using a novel platinum-based linker technology. J Control Release, 111, 193-203. (Pubitemid 43290008)
30. Goodman ZD. (2007). Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol, 47, 598-607. (Pubitemid 47331757)
31. Gressner AM, Bachem MG. (1990). Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis. Semin Liver Dis, 10, 30-46. (Pubitemid 20163704)
32. Greupink R, Bakker HI, Bouma W, Reker-Smit C, Meijer DK, Beljaars L, Poelstra K. (2006). The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo. J Pharmacol Exp Ther, 317, 514-521.
33. Greupink R, Bakker HI, Reker-Smit C, van Loenen-Weemaes AM, Kok RJ, Meijer DK, Beljaars L, Poelstra K. (2005). Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell. J Hepatol, 43, 884-892. (Pubitemid 41414515)
34. Hagens WI, Olinga P, Meijer DK, Groothuis GM, Beljaars L, Poelstra K. (2006). Gliotoxin non-selectively induces apoptosis in fibrotic and normal livers. Liver Int, 26, 232-239.
35. Hattori Y, Kawakami S, Yamashita F, Hashida M. (2000). Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting. J Control Release, 69, 369-377.
36. Kamps JA, Morselt HW, Swart PJ, Meijer DK, Scherphof GL. (1997). Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells. Proc Natl Acad Sci USA, 94, 11681-11685. (Pubitemid 27451058)
37. Kataoka M, Tavassoli M. (1984). Synthetic neoglycoproteins: A class of regents for detection of sugar-recognizing substances. J Histochem Cytochem, 32, 1091-1098. (Pubitemid 14047339)
38. Kawakami S, Sato A, Nishikawa M, Yamashita F, Hashida M. (2000). Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther, 7, 292-299. (Pubitemid 30119732)
39. Kon K, Ikejima K, Hirose M, Yoshikawa M, Enomoto N, Kitamura T, Takei Y, Sato N. (2002). Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride. Biochem Biophys Res Commun, 291, 55-61. (Pubitemid 34681137)
40. Lee MK, Ha NR, Yang H, Sung SH, Kim GH, Kim YC. (2008). Antiproliferative activity of triterpenoids from Eclipta prostrata on hepatic stellate cells. Phytomedicine, 15, 775-780.
41. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. (1995). An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem, 270, 12953-12956.
42. Li D, Friedman SL. (1999). Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J Gastroenterol Hepatol, 14, 618-633. (Pubitemid 29350115)
43. Managit C, Kawakami S, Yamashita F, Hashida M. (2005). Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes. J Pharm Sci, 94, 2266-2275. (Pubitemid 41665286)
44. Martin FJ Heath TD, New RRC (1990). Chapter 4: Covalent attachment of proteins to liposomes. In: New RRC, ed. Liposomes-A Practical Approach. Oxford, England: IRL Press, Oxford University Press, 163-182
45. Milani S, Herbst H, Schuppan D, Grappone C, Heinrichs OE. (1995). Cellular sources of extracellular matrix proteins in normal and fibrotic liver. Studies of gene expression by in situ hybridization. J Hepatol, 22, 71-76.
46. Monsigny M, Roche AC, Midoux P. (1984). Uptake of neoglycoproteins via membrane lectin (s) of L1210 cells evidenced by quantitative flow cytofluorometry and drug targeting. Biol Cell, 51, 187-196. (Pubitemid 15218614)
47. Opanasopit P, Sakai M, Nishikawa M, Kawakami S, Yamashita F, Hashida M. (2002). Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers. J Control Release, 80, 283-294. (Pubitemid 34273766)
48. Pinzani M, Rombouts K, Colagrande S. (2005). Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol, 42 Suppl, S22-S36. (Pubitemid 40364601)
49. Roche AC, Midoux P, Bouchard P, Monsigny M. (1985). Membrane lectins on human monocytes. Maturation-dependent modulation of 6-phosphomannose and mannose receptors. FEBS Lett, 193, 63-68. (Pubitemid 16170826)
50. Rockey DC. (2001). Hepatic blood flow regulation by stellate cells in normal and injured liver. Semin Liver Dis, 21, 337-349. (Pubitemid 32923764)
51. Sliedregt LA, Rensen PC, Rump ET, van Santbrink PJ, Bijsterbosch MK, Valentijn AR, van der Marel GA, van Boom JH, van Berkel TJ, Biessen EA. (1999). Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor. J Med Chem, 42, 609-618. (Pubitemid 29110777)
52. Switzer BR. 1991. Determination of hydroxyproline in tissue. J Nutr Biochem, 2, 229-231.
53. Tsukada S, Parsons CJ, Rippe RA. (2006). Mechanisms of liver fibrosis. Clin Chim Acta, 364, 33-60. (Pubitemid 43120627)
54. Wu J, Zern MA. (2000). Hepatic stellate cells: A target for the treatment of liver fibrosis. J Gastroenterol, 35, 665-672.
55. Ye ZJ, Liu YG. (1985). Effects of tetrachlorvinphos on hepatic microsomal enzymes in the rat. Acta Acad Med Wuhan, 5, 173-177. (Pubitemid 15046699)